Basit öğe kaydını göster

dc.contributor.authorYigit, Serbulent
dc.contributor.authorInanir, Ahmet
dc.contributor.authorTekcan, Akin
dc.contributor.authorInanir, Sema
dc.contributor.authorTural, Sengul
dc.contributor.authorAtes, Omer
dc.date.accessioned2020-06-21T14:04:37Z
dc.date.available2020-06-21T14:04:37Z
dc.date.issued2013
dc.identifier.issn0378-1119
dc.identifier.urihttps://doi.org/10.1016/j.gene.2013.04.020
dc.identifier.urihttps://hdl.handle.net/20.500.12712/15682
dc.descriptionYigit, Serbulent/0000-0002-1019-3964en_US
dc.descriptionWOS: 000323589100008en_US
dc.descriptionPubMed: 23644020en_US
dc.description.abstractPurpose: Fibromyalgia (FM) syndrome is a form of non-articular rheumatism characterized by long term and widespread musculoskeletal pain, morning stiffness, sleep disturbance, paresthesia, and pressure hyperalgesia at characteristic sites, called soft tissue tender points. The etiology of FM is still obscure. Genetic factors may predispose individuals to FM. Cytokines may play a role in the pathophysiology of FM. The aim of this study was to investigate the interleukin-4 (IL-4) 70 bp VNTR variations in Turkish patients with FM and evaluate if there was an association with clinical features, especially between these polymorphisms. Methods: The study included 300 patients with FM and 270 healthy controls. Genomic DNA was isolated and genotyped using polymerase chain reaction (PCR) for the IL-4 gene 70 bp VNTR polymorphisms. Results: There was statistically significant difference between the groups with respect to IL-4 genotype distribution and allele frequencies (p < 0.0001). The homozygous P1P1 genotype and P-1 allele were significantly higher in FM patients than in healthy controls (p = 0.04; OR: 325, 95% CI: 1-10, p < 0.0001; OR:4.84, 95% CI:3-7.7). There was not any difference between the groups respect to IL-4 genotype distribution and allele frequencies (p > 0.05) and clinical characteristics. Conclusion: Our findings suggest that there is an association of IL-4 gene 70 bp VNTR polymorphism with susceptibility of a person for development of FM. As a result, further studies are necessary to determine whether IL-4 may be a genetic marker for FM in the Turkish population. (C) 2013 Elsevier B.V. All rights reserved.en_US
dc.language.isoengen_US
dc.publisherElsevier Science Bven_US
dc.relation.isversionof10.1016/j.gene.2013.04.020en_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectFibromyalgia syndromeen_US
dc.subjectInterleukin-4 gene (IL-4)en_US
dc.subjectPolymorphismen_US
dc.titleAssociation between fibromyalgia syndrome and polymorphism of the IL-4 gene in a Turkish populationen_US
dc.typearticleen_US
dc.contributor.departmentOMÜen_US
dc.identifier.volume527en_US
dc.identifier.issue1en_US
dc.identifier.startpage62en_US
dc.identifier.endpage64en_US
dc.relation.journalGeneen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster